severe-asthma

Documents about severe-asthma

• Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab".#840810ClinicalTrials.gov
• Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma#862377ClinicalTrials.gov
• Managing multimorbidity in severe asthma: comparison of resources and perspectives between severe asthma specialists and general respiratory physicians across Europe#224385HAL (France)
• Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy#850421ClinicalTrials.gov
• A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma#860351ClinicalTrials.gov
• ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults#869829ClinicalTrials.gov
• Effect of Mepolizumab on Severe Eosinophilic Asthma#879775ClinicalTrials.gov
• Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma#992061ClinicalTrials.gov
• Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma#847169ClinicalTrials.gov
• Risk Factors for Early Remodelling in Severe Asthma in Children#916309ClinicalTrials.gov
• Phase I Assessment of Hypertonic Saline in Moderate to Severe Asthmatics#866059ClinicalTrials.gov
• Prevalence of Hyperventilation Syndrome in Difficult Asthma#883524ClinicalTrials.gov
• Bilevel Positive Airway Pressure (BPAP) for Severe Asthma#905618ClinicalTrials.gov
• Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers#813841ClinicalTrials.gov
• IL-13 Blockade and Airway Autoimmunity in Asthma#872126ClinicalTrials.gov
• Study of CM512 Injection in Subjects With Moderate-to-severe Asthma#902152ClinicalTrials.gov
• Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations#854974ClinicalTrials.gov
• Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency Department#886020ClinicalTrials.gov
• Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma#980679ClinicalTrials.gov
• Timing of High-Risk Asthma Specialist Enrollment and Severe Asthma Exacerbations in Children.#371492NCBI PubMed Central
• Tezepelumab on Airway Structure and Function in Patients With Uncontrolled Moderate-to-severe Asthma#836246ClinicalTrials.gov
• A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)#867860ClinicalTrials.gov
• Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma#881833ClinicalTrials.gov
• Uncontrolled and Possible Severe Asthma in Denmark#993693ClinicalTrials.gov
• EFFECTIVENESS of PROBIOTICS in ADULTS with MODERATE to SEVERE PERSISTENT ASTHMA#810104ClinicalTrials.gov
• The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma#914771ClinicalTrials.gov
• Features of asthma which provide meaningful insights for understanding the disease heterogeneity#954909Koc University Digital Collections
• Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry#610834Bielefeld Pub
• Unraveling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma (TASMA) Extension Study#969604ClinicalTrials.gov
• Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.#810606ClinicalTrials.gov
• Efficacy and Safety Study of 610 in Patients With Severe Asthma#838477ClinicalTrials.gov
• Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma#866032ClinicalTrials.gov
• A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent Asthma#869242ClinicalTrials.gov
• An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma#887887ClinicalTrials.gov
• Psychological Characteristics of Patients With Severe Asthma#910898ClinicalTrials.gov
• Controller Medications in the Management of Bronchial Asthma#992454ClinicalTrials.gov
• Study on the Effects of Sitaxsentan on Airway Remodeling in Patients With Severe Asthma#1009990ClinicalTrials.gov
• Non-coding RNAs Analysis of Eosinophil Subtypes in Asthma#855275ClinicalTrials.gov
• Improving the Quality of Care for Asthma Patients at Risk of Exacerbations#851273ClinicalTrials.gov
• A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab#882548ClinicalTrials.gov
• DETACT sEvere asThmAtiC paTients - a Pilot Study#871439ClinicalTrials.gov
• Dog allergen-induced asthma in mice: a relevant model of T2low severe asthma with airway remodelling#308376HAL (France)
• Patients With Severe Eosinophilic Asthma Treated With Benralizumab#844258ClinicalTrials.gov
• Pulmonary Rehabilitation for Uncontrolled Asthma Associated With Elevated BMI#878348ClinicalTrials.gov
• Severe Asthma, MepolizumaB and Affect: SAMBA Study#806513ClinicalTrials.gov
• TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)#907784ClinicalTrials.gov
• Acute Effect of Mometasone on Beta-adrenergic Airway and Airway Vascular Relaxation in Severe Asthma#911552ClinicalTrials.gov
• Effect of a 12-month Pharmaceutical Care Program on Control of Severe Asthma#801466ClinicalTrials.gov
• Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma#871954ClinicalTrials.gov
• Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma#892984ClinicalTrials.gov